Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy

Summary

This is an observational, open-label, flexible dose study that will prospectively and longitudinally assess the effect of Cannabidiol (CBD) therapy in patients with drug-resistant epilepsies through a Physician Expanded Access Investigational New Drug protocol.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications